Showing 1 - 1 of 1
Business, Lamonphet Apisitniran, Published on 19/02/2020
» Thai pharmaceutical maker Siam Bioscience Group plans to produce and sell three new drugs for complicated diseases -- cancer, kidney failure and autoimmune diseases -- by 2022 both domestically and abroad.